Cost effectiveness of alternative imaging strategies for the diagnosis of small-bowel crohn's disease

DSpace/Manakin Repository

Cost effectiveness of alternative imaging strategies for the diagnosis of small-bowel crohn's disease

Citable link to this page

 

 
Title: Cost effectiveness of alternative imaging strategies for the diagnosis of small-bowel crohn's disease
Author: Levesque, Barrett G.; Cipriano, Lauren E.; Chang, Steven L.; Lee, Keane K.; Owens, Douglas K.; Garber, Alan M

Note: Order does not necessarily reflect citation order of authors.

Citation: Levesque, Barrett G., Lauren E. Cipriano, Steven L. Chang, Keane K. Lee, Douglas K. Owens, and Alan M. Garber. 2010. Cost effectiveness of alternative imaging strategies for the diagnosis of small-bowel crohn s disease. Clinical Gastroenterology and Hepatology 8, 3:261-267.
Access Status: Full text of the requested work is not available in DASH at this time (“dark deposit”). For more information on dark deposits, see our FAQ.
Full Text & Related Files:
Abstract: Background & Aims
The cost effectiveness of alternative approaches to the diagnosis of small-bowel Crohn's disease is unknown. This study evaluates whether computed tomographic enterography (CTE) is a cost-effective alternative to small-bowel follow-through (SBFT) and whether capsule endoscopy is a cost-effective third test in patients in whom a high suspicion of disease remains after 2 previous negative tests.

Methods
A decision-analytic model was developed to compare the lifetime costs and benefits of each diagnostic strategy. Patients were considered with low (20%) and high (75%) pretest probability of small-bowel Crohn's disease. Effectiveness was measured in quality-adjusted life-years (QALYs) gained. Parameter assumptions were tested with sensitivity analyses.

Results
With a moderate to high pretest probability of small-bowel Crohn's disease, and a higher likelihood of isolated jejunal disease, follow-up evaluation with CTE has an incremental cost-effectiveness ratio of less than $54,000/QALY-gained compared with SBFT. The addition of capsule endoscopy after ileocolonoscopy and negative CTE or SBFT costs greater than $500,000 per QALY-gained in all scenarios. Results were not sensitive to costs of tests or complications but were sensitive to test accuracies.

Conclusions
The cost effectiveness of strategies depends critically on the pretest probability of Crohn's disease and if the terminal ileum is examined at ileocolonoscopy. CTE is a cost-effective alternative to SBFT in patients with moderate to high suspicion of small-bowel Crohn's disease. The addition of capsule endoscopy as a third test is not a cost-effective third test, even in patients with high pretest probability of disease.
Published Version: 10.1016/j.cgh.2009.10.032
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:11595668
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters